WHO: Nations mulling Gilead's COVID drug should consider trial flop, too

WHO: Nations mulling Gilead's COVID drug should consider trial flop, too

Source: 
Reuters
snippet: 

Health officials reviewing Gilead Science Inc’s remdesivir against COVID-19 should consider all evidence, including a trial in which the medicine failed, before giving it the green light, the top WHO scientist said on Friday.